Medically reviewed by John Carew, MD Fact checked by Jillian Dara Nasal sprays can treat congestion and other symptoms of seasonal allergies or a cold. They work by delivering a fine mist of ...

A nasal spray that contains esketamine — a potent derivative of ketamine — can now be taken on its own to treat adults with ...

CIII allows people who have tried at least two oral antidepressants to use the spray on its own – without the need for more ...

Revolutionary nasal spray offers hope by potentially delaying Alzheimer's progression through cutting-edge neurological ...

The U.S. Food and Drug Administration ( FDA) has approved the use of a nasal spray as a standalone treatment for major depressive disorder, offering a new option for those struggling with ...

Avoid spraying the medication into your eyes or onto the middle of the inside of your nose (nasal septum). Rinse the spray tip with hot water or wipe with a clean tissue after each use.

Pharmaceuticals Inc. (Nasdaq: MIST), a biopharmaceutical company focused ... Milestone’s New Drug Application (NDA) for CARDAMYST™ (etripamil) nasal spray, its lead investigational product ...

The FDA has accepted for review the NDA for bumetanide nasal spray for edema associated with CHF, as well as hepatic and renal disease.

The expanded indication allows esketamine nasal spray to be used as a standalone treatment in adults with MDD who have not ...

PDUFA date of March 27, 2025 for CARDAMYST™ (etripamil) nasal spray for Paroxysmal Supraventricular ... Milestone® Pharmaceuticals Inc. (Nasdaq: MIST), a biopharmaceutical company focused ...